STOCK TITAN
  1. Home
  2. Sec-filings
  3. TGTX
  4. [Form 4] TG THERAPEUTICS, INC. Insider Trading Activity

TG Therapeutics (NASDAQ: TGTX) director awarded 8,325 stock tracking units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Echelard Yann reported acquisition or exercise transactions in this Form 4 filing.

TG Therapeutics director Yann Echelard received a grant of 8,325 stock tracking units as equity compensation. Each unit represents a contingent right to receive either one share of common stock or a cash payment equal to the fair market value of one share. The committee administering the company’s 2022 Incentive Plan will choose stock or cash, and settlement must occur within 30 days after the first anniversary of the grant date. The units vest on the first anniversary of grant if Echelard remains in continuous service with the company.

Positive

  • None.

Negative

  • None.
Insider Echelard Yann
Role null
Type Security Shares Price Value
Grant/Award Stock Tracking Unit 8,325 $0.00 --
Holdings After Transaction: Stock Tracking Unit — 8,325 shares (Direct, null)
Footnotes (1)
  1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.
Stock tracking units granted 8,325 units Grant to director on 2026-06-11
Transaction price per unit $0.00 Equity award, not open-market purchase
Underlying common shares 8,325 shares Each unit tied to one common share
Vesting schedule 1-year cliff Vests on first anniversary of grant
Settlement window Within 30 days After first anniversary of grant date
Stock Tracking Unit financial
"Each stock tracking unit ("STU") represents a contingent right to receive either..."
contingent right financial
"represents a contingent right to receive either (determined at the sole discretion..."
fair market value financial
"a cash payment equal to the fair market value of one share of the Issuer's common stock..."
The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.
2022 Incentive Plan financial
"the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan..."
A 2022 incentive plan is a formal program adopted in 2022 that outlines how a company will reward employees, executives, or directors with cash, stock, or other benefits tied to performance or continued service. Investors care because these plans can change how much ownership exists (dilution), affect reported profits through compensation costs, and influence whether managers are motivated to increase long‑term value—think of it as the rules for a company’s bonus and stock‑award system.
vesting financial
"the STUs shall vest upon the first anniversary of the date of grant..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Echelard Yann
(Last)(First)(Middle)
3020 CARRINGTON MILL BLVD, SUITE 475
(Street)
MORRISVILLE NORTH CAROLINA 27560
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
TG THERAPEUTICS, INC. [ TGTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Tracking Unit(1)06/11/2026A8,325 (2) (2)Common Stock8,325$08,325D
Explanation of Responses:
1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.
2. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.
/s/ Yann Echelard06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did TG Therapeutics (TGTX) director Yann Echelard report on this Form 4?

Yann Echelard reported receiving 8,325 stock tracking units as an equity award. These units are linked to TG Therapeutics common stock and provide a contingent right to future stock or cash value, subject to vesting and plan terms.

How many stock tracking units did Yann Echelard receive from TG Therapeutics (TGTX)?

Echelard received 8,325 stock tracking units in this transaction. Each unit corresponds to a contingent right tied to one share of TG Therapeutics common stock, either in actual shares or an equivalent cash amount after the vesting period.

What is a stock tracking unit in the TG Therapeutics (TGTX) Form 4 filing?

Each stock tracking unit represents a contingent right to receive either one share of TG Therapeutics common stock or a cash payment equal to that share’s fair market value. The choice between stock and cash is made by the plan’s administering committee.

When do Yann Echelard’s TG Therapeutics (TGTX) stock tracking units vest and settle?

The stock tracking units vest on the first anniversary of the grant date, provided Echelard remains in continuous service with TG Therapeutics. Settlement in stock or cash must occur within 30 days after that first anniversary, under the plan’s terms.

Was Yann Echelard’s TG Therapeutics (TGTX) transaction an open-market buy or sell?

No, the transaction was a grant or award acquisition of 8,325 stock tracking units at a price of $0.00 per unit. It reflects equity compensation under the company’s 2022 Incentive Plan, not an open-market purchase or sale of shares.